INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 10th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • New York
This Agreement is being entered into in connection with a closing pursuant to that certain Securities Purchase Agreement, dated as of _______, 20__, by and among the Company and the Initial Purchasers (the “Initial Purchase Agreement”) and in connection with the closing on the date hereof pursuant to the Securities Purchase Agreement, dated as of _______, 20__.
ASSET PURCHASE AGREEMENT between ACURX PHARMACEUTICALS, LLC and GLSYNTHESIS INC., Dated February 5, 2018 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 10th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • Delaware
ASSET PURCHASE AGREEMENT (the "Agreement") dated February 5, 2018 (the “Effective Date”), by and between Acurx Pharmaceuticals, LLC, a limited liability company organized and existing under the laws of Delaware having a principal place of business at 22 Camelot Court, White Plains, NY 10603 (the “Purchaser”) and GLSynthesis Inc., a Massachusetts corporation having a principal place of business at 298 Highland Street, Worcester, MA 01602 (the “Seller” and, together with the Purchaser, the “Parties”).
MASTER CLINICAL SERVICES AGREEMENTMaster Clinical Services Agreement • May 10th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • Delaware
This MASTER CLINICAL SERVICES AGREEMENT (“Agreement”), effectively dated as of the last date of authorized signature herein (“Effective Date”), is made by and between Acrux Pharmaceuticals, LLC, a Delaware limited liability company (“Sponsor”), with principal offices located at 22 Camelot Court, White Plains, NY 10603 and Syneos Health, LLC, a Delaware limited liability company, with principal offices located in the United States at 1030 Sync Street, Morrisville, North Carolina 27560, together with Syneos Health UK Limited, a company with principal offices located at Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, England, Europe (“Syneos Health”).
